Ezlopitant

N/A

Report date: 2022/05/18 11:41:01

NME

Base Information

Drug NameEzlopitant

Drug Alias Name依洛匹坦CJ-12458CP-12458CP-12764CP-611781 +[8]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNeurokinin 1 receptor antagonists

TargetsNeurokinin 1 receptor

Therapy Area/IndicationsNausea

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsNausea

ATC CodeN/A